Search
for
Sort by
Research 181–210 of 1000+
- Androgenic disorders
- [Contraceptive methods for adolescents].
- Sebaceous gland diseases: clinical picture risk factors and treatment
- Acne
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- ANTIANDROGEN TREATMENT OF POLYCYSTIC OVARY SYNDROME
- Characteristics of Androgenetic Alopecia in Asian
- Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
- Endocrinological evaluation and hormonal therapy for women with difficult acne
- Obesity and the Polycystic Ovary Syndrome
- Medical management of male pattern hair loss
- Choice of treatment for women with polycystic ovary syndrome
- Prioritization of therapy uncertainties in congenital ichthyosis: results from a Priority Setting Partnership
- Epidemiology and Management of Acne in Adult Women
- Management of hidradenitis suppurativa
- Polycystic Ovary Syndrome (PCOS) and Sexual Dysfunctions
- Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?
- Efficacy and safety of minoxidil therapy: A systematic review and meta-analysis weighing the benefits against the risk of hypertrichosis
- Use of Platelet-Rich Plasma in the Management of Alopecia Areata
- Dermatolojik Problemler ve COVID-19
- 28665 Cutaneous T-cell lymphoma (CTCL) outcomes during COVID-19
- The skin findings of pregnant women and our treatment choices. A Turkish experience: a 5-year survey.
- Basics of Hormonal Contraception
- Disturbance of the Circadian System in Shift Work and Its Health Impact
- Guidelines on the use of finasteride in androgenetic alopecia
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Polycystic Ovary Syndrome (PCOS): Causes, Symptoms, Diagnosis & Treatments
- Polycystic ovary syndrome in North America
- Antiandrogens and Androgen Inhibitors
- Management of teenagers with polycystic ovarian syndrome